Aehr Test Systems (AEHR) Set for Q4 Earnings Announcement

Author's Avatar
Jul 07, 2025
Article's Main Image
  • Aehr Test Systems (AEHR, Financial) is set to announce its Q4 earnings on July 8th, with expected EPS showing a significant decline.
  • Analysts offer a mixed outlook with an average price target indicating a potential downside, yet the GF Value suggests a substantial upside.
  • The stock's current consensus recommendation shows a favorable "Outperform" status.

Upcoming Earnings Release

Aehr Test Systems (AEHR) is gearing up to announce its fourth-quarter earnings results after the market closes on July 8th. Investors should note that analysts are projecting an earnings per share (EPS) of -$0.01, reflecting a significant decrease of 101.2% compared to the same period last year. Additionally, the anticipated revenue is $14.82 million, marking a 10.7% decline year-over-year.

Wall Street Analysts Forecast

1942344223571472384.png

When examining the projections from two analysts, the average one-year price target for Aehr Test Systems (AEHR, Financial) is set at $12.75. The forecasts range from a high estimate of $14.00 to a low of $11.50. This average target price indicates a potential downside of 13.97% from the current market price of $14.82. For a more comprehensive view of the estimates, visit the Aehr Test Systems (AEHR) Forecast page.

In terms of analyst recommendations, the stock receives an average brokerage recommendation of 2.3 across three firms, suggesting an "Outperform" status on the rating scale where 1 indicates a Strong Buy and 5 reflects a Sell.

GF Value and Market Outlook

According to GuruFocus estimates, the projected GF Value of Aehr Test Systems (AEHR, Financial) in a year's time is estimated to be $20.63. This suggests a potential upside of 39.2% from its current trading price of $14.82. The GF Value represents GuruFocus’ fair value projection, derived from historical trading multiples, the company's previous growth, and anticipated future performance. To explore more data regarding this valuation, please visit the Aehr Test Systems (AEHR) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.